[Treatment of GERD in asthma]

Rev Mal Respir. 2021 Sep;38(7):733-742. doi: 10.1016/j.rmr.2021.04.013. Epub 2021 May 18.
[Article in French]

Abstract

Gastro-oesophageal reflux disease (GORD) is one of the most frequent conditions associated with asthma. GORD has an impact on asthma control and quality of life of asthmatic patients. Its treatment relies on lifestyle modifications, anti-acidic treatment with proton pump inhibitors (PPI) and/or surgical management by fundoplication in some situations. The impact of lifestyle modifications has not been analysed on asthma outcomes alone. Several randomised controlled trials assessed the efficacy of PPI on asthma control, peak expiratory flow and/or quality of life. The impact of fundoplication in asthma has mainly been analysed in retrospective or prospective observational studies. This review highlights the limited impact of GORD treatment on asthma control. Current guidelines are to restrict GORD treatment in asthma to asthmatic patients with actual symptomatic GORD. Given the lack of controlled studies, the place of surgical management of GORD in asthma is currently not defined.

Keywords: Asthma; Asthme; Fundoplication; Fundoplicature; Gastroesophageal reflux disease; Inhibiteur de la pompe à protons; Proton pump inhibitor; Reflux gastro-œsophagien.

Publication types

  • Review

MeSH terms

  • Asthma* / complications
  • Asthma* / epidemiology
  • Asthma* / therapy
  • Gastroesophageal Reflux* / complications
  • Gastroesophageal Reflux* / epidemiology
  • Gastroesophageal Reflux* / therapy
  • Humans
  • Observational Studies as Topic
  • Proton Pump Inhibitors / therapeutic use
  • Quality of Life
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Proton Pump Inhibitors